Rein Therapeutics, Inc. Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax
Rein Therapeutics, Inc. (RNTX) had Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax of $2.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2026-08-14
- 2026-06-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $2.00K.
- 2021-09-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $2.00K.
- 2021-06-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $6.00K.
- 2021-03-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $2.00K.
| Period end | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-14 |
| 2021-09-30 | $2.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $6.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $2.00K 10-Q · filed 2021-05-11 |
| 2020-03-31 | $1.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $8.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $17.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $24.00K 10-Q · filed 2019-08-06 |
| 2017-09-30 | $2.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |